0
0
0
Combating Illicit Xylazine Act
3/13/2025, 3:23 PM
Summary of Bill HR 1266
Bill 119 HR 1266, also known as the "Xylazine Prohibition Act," aims to restrict the use of xylazine for certain purposes. Xylazine is a sedative commonly used in veterinary medicine, but it has also been misused as a recreational drug and in criminal activities.
The bill prohibits the use of xylazine for non-medical purposes, such as in the production or distribution of illicit drugs. It also prohibits the use of xylazine in any form of animal fighting, including cockfighting and dogfighting.
Additionally, the bill includes provisions for increased penalties for individuals found in violation of the xylazine prohibition. This includes fines and potential imprisonment for those caught using xylazine for illegal purposes. Overall, the Xylazine Prohibition Act seeks to address the misuse of xylazine and protect both animals and communities from the harmful effects of its misuse.
The bill prohibits the use of xylazine for non-medical purposes, such as in the production or distribution of illicit drugs. It also prohibits the use of xylazine in any form of animal fighting, including cockfighting and dogfighting.
Additionally, the bill includes provisions for increased penalties for individuals found in violation of the xylazine prohibition. This includes fines and potential imprisonment for those caught using xylazine for illegal purposes. Overall, the Xylazine Prohibition Act seeks to address the misuse of xylazine and protect both animals and communities from the harmful effects of its misuse.
Read the Full Bill
Current Status of Bill HR 1266
Bill HR 1266 is currently in the status of Bill Introduced since February 12, 2025. Bill HR 1266 was introduced during Congress 119 and was introduced to the House on February 12, 2025. Bill HR 1266's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of February 12, 2025
Bipartisan Support of Bill HR 1266
Total Number of Sponsors
8Democrat Sponsors
8Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
166Democrat Cosponsors
79Republican Cosponsors
87Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 1266
Primary Policy Focus
Alternate Title(s) of Bill HR 1266
To prohibit certain uses of xylazine, and for other purposes.
To prohibit certain uses of xylazine, and for other purposes.
Comments
Phoebe Vick
963
1 year ago
So excited for this! It's about time we put a stop to those harmful uses of xylazine. #HRBill1266 #prohibitxylazine
Sponsors and Cosponsors of HR 1266
Latest Bills
Blue Skies for Taiwan Act of 2026
Bill HR 9042June 6, 2026
Protecting Academic Integrity Act of 2026
Bill HR 9074June 6, 2026
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Bill HR 9170June 6, 2026
Deport Alien Gang Members Act
Bill HR 175June 6, 2026
Deport the Terrorists Act of 2026
Bill HR 9096June 6, 2026
PANA Act of 2026
Bill HR 9039June 6, 2026
To prohibit the use of Federal funds to install permanent fencing around the United States Supreme Court Building or grounds.
Bill HR 9038June 6, 2026
To amend the Federal Election Campaign Act of 1971 to make it a felony offense for any person who is seeking to be a candidate in an election for Federal office or an employee or agent of such a person to knowingly fraudulently sign any materials or documentation required to be filed as a condition of ballot access for such election, and for other purposes.
Bill HR 8977June 6, 2026
To amend the Higher Education Act of 1965 to provide enhanced student loan relief to educators, and for other purposes.
Bill HR 8896June 6, 2026
To direct the Administrator of the Federal Aviation Administration to improve and expand electronic filing capabilities for Federal Aviation Administration Form 337, and for other purposes.
Bill HR 9037June 6, 2026